NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 52 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,033 | -47.0% | 61,713 | +28.2% | 0.00% | – |
| Q2 2023 | $124,703 | -67.5% | 48,148 | -48.8% | 0.00% | – |
| Q1 2023 | $383,568 | +64.7% | 94,012 | +102.6% | 0.00% | – |
| Q4 2022 | $232,903 | -99.6% | 46,395 | -98.9% | 0.00% | -100.0% |
| Q3 2022 | $56,560,000 | +114.1% | 4,324,201 | +109.9% | 0.01% | +100.0% |
| Q2 2022 | $26,416,000 | +36.0% | 2,060,533 | +61.8% | 0.00% | +50.0% |
| Q1 2022 | $19,417,000 | -15.7% | 1,273,186 | -2.1% | 0.00% | 0.0% |
| Q4 2021 | $23,043,000 | -16.2% | 1,301,138 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $27,493,000 | +588.7% | 1,307,937 | +353.8% | 0.00% | – |
| Q3 2019 | $3,992,000 | -5.4% | 288,200 | 0.0% | 0.00% | – |
| Q2 2019 | $4,219,000 | – | 288,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |